Intravenous administration of glucose and fructose in the uncomplicated postoperative period.
D000136:Acid-Base Equilibrium; D000255:Adenosine Triphosphate / Q000378:metabolism; D001786:Blood Glucose / Q000378:metabolism; D002021:Buffers; D005374:Filtration / Q000295:instrumentation; D005632:Fructose / Q000008:administration & dosage* / Q000378:metabolism; D005947:Glucose / Q000008:administration & dosage* / Q000378:metabolism; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D008099:Liver / Q000378:metabolism; D010288:Parenteral Nutrition / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D010710:Phosphates / Q000097:blood; D011184:Postoperative Period; D011506:Proteins / Q000378:metabolism; D013514:Surgical Procedures, Operative; D013924:Thrombophlebitis / Q000209:etiology; D014527:Uric Acid / Q000097:blood
D001786:Blood Glucose; D002021:Buffers; D010710:Phosphates; D011506:Proteins; D014527:Uric Acid; D005632:Fructose; D000255:Adenosine Triphosphate; D006493:Heparin; D005947:Glucose; D006854:Hydrocortisone